Limits to chemical hormesis as a dose-response model in health risk assessment

Science of the Total Environment

Volumn 443, Issue , 2013, Pages 643-649

  Mushak, Paul ^a  

^a NONE   (United States)

Author keywords

Dose response relationships; Hormesis; Nonmonotonic dose responses

Indexed keywords

HEALTH; HEALTH RISKS;

CRITICAL EVALUATION; DOSE RESPONSE RELATIONSHIPS; DOSE-RESPONSE MODELING; HORMESIS; HUMAN HEALTH RISK ASSESSMENT; NON-MONOTONIC DOSE; RELIABILITY AND STABILITY; TOXICOLOGICAL RESPONSE;

RISK ASSESSMENT;

CARCINOGEN; XENOBIOTIC AGENT;

HEALTH RISK; NUMERICAL MODEL; RISK ASSESSMENT; TEMPORAL ANALYSIS; TOXICOLOGY;

BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CHEMICAL HORMESIS; CHEMICAL PARAMETERS; COMPARATIVE STUDY; ECOTOXICOLOGY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL STRESS; GLOMERULUS FILTRATION; HOMEOSTASIS; HORMESIS; HUMAN; NONHUMAN; OVERCOMPENSATION; PRIORITY JOURNAL; PROTECTION; RELIABILITY; REVIEW; RISK ASSESSMENT; THRESHOLD DOSE RESPONSE; XENOBIOTIC METABOLISM;

EID: 84870717931     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2012.11.017     Document Type: Review

References (46)

1. Aygun B., Mortier N.A., Smeltzer M.P., Hankins J.S., Ware R.E. Glomerular hyperfiltration and albuminuria in children with sickle cell anemia. Pediatr Nephrol 2011, 26:1285-1290.
2. Brenner B.M., Lawler E.V., MacKenzie H.S. The hyperfiltration theory: a paradigm drift in nephrology. Kidney Int 1996, 49:1774-1777.
3. Bulayeva N.N., Watson C.S. Xenoestrogen-induced ERK-1 and ERK-2 activation via multiuple membrane-initiated signaling pathways. Environ Health Perspect 2004, 112:1481-1487.
4. Calabrese E.J. Threshold dose-response model-RIP: 1911 to 2006. Bioessays 2007, 29:686-688.
5. Calabrese E.J. The future of hormesis: where do we go from here?. Crit Rev Toxicol 2001, 31:637-648.
6. Calabrese E.J. Hormesis: why it is important to toxicology and toxicologists. Environ Toxicol Chem 2008, 27:1451-1474.
7. Calabrese E.J., Baldwin L.A. The frequency of U-shaped dose-responses in the toxicological literature. Toxicol Sci 2001, 62:330-338.
8. Calabrese E.J., Baldwin L.A. U-shaped dose-responses in biology, toxicology, and public health. Annu Rev Public Health 2001, 22:15-33.
9. Calabrese E.J., Baldwin L.A. Defining hormesis. Hum Exp Toxicol 2002, 21:91-97.
10. Calabrese E.J., Mattson M.P. Hormesis provides a generalized quantitative estimate of biological plasticity. J Cell Commun Signal 2011, 5:25-38.
11. Calabrese E.J., Staudenmayer J.W., Stanek E.J., Hoffmann G.R. Hormesis outperforms threshold model in NCI antitumor drug screening data. Toxicol Sci 2006, 94:368-378.
12. Calabrese E.J., Bachmann K.A., Bailer A.J., Bolger P.M., Borak J., Cai L., et al. Biological stress response terminology: integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol 2007, 222:122-128.
13. Calabrese E.J., Stanek E.J., Nascarella M.A., Hoffmann G.R. Hormesis predicts low-dose responses better than threshold models. Int J Toxicol 2008, 27:369-378.
14. DeBurbure C., Buchet J.-P., Leroyer A., Nisse C., Haguenoer J.-M., Mutti A., et al. Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environ Health Perspect 2006, 114:584-590.
15. Fagin D. The learning curve. Nature 2012, 490:462-465.
16. Griffin K.A., Kramer H., Bidani A.K. Adverse renal consequences of obesity. AJR Ren Physiol 2008, 294:F685-F696.
17. Hoffmann G.R. A perspective on the scientific, philosophical and policy dimensions of hormesis. Dose Response 2009, 7:1-51.
18. Kaiser J. Sipping from a poisoned chalice. Science 2003, 302:376-379.
19. Kendig E.L., Le H.H., Belcher S.M. Defining hormesis: evaluation of a complex concentration response phenomenon. Int J Toxicol 2010, 29:235-246.
20. Khalil-Manesh F., Gonick H.C., Cohen A.H., Alinovi R., Bergamaschi E., Mutti A., et al. Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int 1992, 41:1192-1203.
21. Khalil-Manesh F., Gonick H.C., Cohen A. Experimental model of lead nephropathy. III. Continuous low-level lead administration. Arch Environ Health 1993, 48:271-278.
22. Kitchin K.T., Drane J.W. A critique of the use of hormesis in risk assessment. Hum Exp Toxicol 2005, 24:249-253.
23. Loghman-Adham M. Renal effects of environmental and occupational lead exposure. Environ Health Perspect 1997, 105:928-939.
24. Magee G.M., Bilous R.W., Cardwell C.R., Hunter S.J., Kee F., Fogarty D.E. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 2009, 52:691-697.
25. Hormesis: a revolution in biology, toxicology and medicine 2009, Humana Press, New York. M.P. Mattson, E.J. Calabrese (Eds.).
26. Metcalfe W., Seymour C. How does early chronic kidney disease progress? A background paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease. Nephrol Dial Transplant 2007, 22:ix26-ix30. (Suppl.9).
27. Mothersill C., Seymour C. Changing paradigms in radiobiology. Mutat Res 2012, 750:85-95.
28. Mushak P. Hormesis and its place in nonmonotonic dose-response relationships. Some scientific reality checks. Environ Health Perspect 2007, 115:500-506.
29. Mushak P. Ad hoc and fast forward: the science of hormesis growth and development. Environ Health Perspect 2009, 117:1333-1338.
30. Mushak P. Hormesis: a brief reply to an advocate. Environ Health Perspect 2010, 118:A513.
31. Myers J.P., Zoeller R.T., vom Saal F.S. A clash of old and new scientific concepts in toxicity, with important implications for public health. Environ Health Perspect 2009, 117:1652-1655.
32. NAS/NRC. National Academy of Sciences/National Research Council Health risks from exposure to low levels of ionizing radiation. BEIR VII - phase 2 2006, National Academy Press, Washington, D.C.
33. NAS/NRC. National Academy of Sciences/National Research Council Science and decisions. Advancing risk assessment 2009, National Academy Press, Washington, D.C.
34. NAS/NRC. National Academy of Sciences/National Research Council Risk assessment in the federal government: managing the process 1983, National Academy Press, Washington, D.C.
35. Nenov V.D., Taal M.W., Sakharova O.V., Brenner B.M. Multi-hit nature of chronic renal disease. Curr Opin Nephrol Hypertens 2000, 9:85-97.
36. Effects and dose-response relationships of toxic metals 1976, Elsevier, Amsterdam, Netherlands. G.F. Nordberg (Ed.).
37. Palatini P. Glomerular hyperfiltration: a marker of early renal damage in pre-diabetes and pre-hypertension. Nephrol Dial Transplant 2012, 27:1708-1714.
38. Roels H., Lauwerys R., Konings J., Buchet J.P., Bernard A., Green S., et al. Renal function and hyperfiltration capacity in lead smelter workers with high bone lead. Occup Environ Med 1994, 51:505-512.
39. Sasson A.N., Cherney D.Z.I. Renal hyperfiltration related to diabetes mellitus and obesity in human disease. World J Diab 2012, 3:1-6.
40. Thayer K.A., Melnick R., Burns K., Davis D., Huff J. Fundamental flaws of hormesis for public health decisions. Environ Health Perspect 2005, 113:1271-1276.
41. U.S. EPA A review of the Reference Dose and Reference Concentration processes 2002, U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, D.C., [EPA/630/P-02/002F].
42. U.S. EPA Integrated Risk Information System (IRIS). IRIS process URL:, Accessed October 28, 2012. http://www.epa.gov/iris/process.htm.
43. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R., Lee D.H., et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocrin Rev 2012, 33:378-455.
44. vom Saal F.S. Hormesis controversy. Environ Sci Technol 2007, 41:3. (Letter).
45. vom Saal F.S., Akingbemi B.T., Belcher S.M., Birnbaum L.S., Crain D.A., Farabollini F., et al. Chapel Hill expert panel consensus statement: integration of mechanisms, effects in animals, and potential to impact human health at current levels of exposure. Reprod Toxicol 2007, 24:199-224.
46. Weaver V.M., Lee B.-K., Ahn K.D., Lee G.S., Todd A.C., Stewart W.F., et al. Association of lead biomarkers with renal function in Korean lead workers. Occup Environ Med 2003, 60:551-562.